Alon Maor joined BRM in 2011 and leads the firm’s life sciences investments. He brings more than 25 years of experience in healthcare, having served in senior executive roles across the global medical technology industry.

Prior to joining BRM, Alon founded Aesthera Corporation, a Kleiner Perkins–backed company developing light-based technologies for dermatological treatments. He served as CEO and Chairman from the company’s inception through its acquisition by Solta Medical in 2010. Earlier in his career, Alon held executive positions at multiple medtech companies in both Japan and the United States.

Hobbies:

• Baking
• Yoga & other sports